Which company develops and produces tucatinib/tucatinib?

Tucatinib/Tucatinib’s trade name is Tukysa, which is an anti-cancer drug used to treat HER2 positive breast cancer. It is a small molecule inhibitor of HER2. Tucatinib was developed by Array BioPharma and licensed to Cascadian Therapeutics (formerly Oncothyreon and later part of Seattle Genetics).

Tucatinib was approved for medical use in the United States in20204month,2020< /span>8 months in Australia and join the EU in 20212 months. Tucatinib is a kinase inhibitor. The chemical name is (N4-([1, 2, 4]triazolo 【1, 5-a]pyridine-7-yloxy)-3-methyl phenyl)-N6-(4, 4-Dimethyl-4,< /span>5-dihydrazole-2-yl) quinazoline-4, 6-diamine. The molecular formula is C26H24N8O2 and the molecular weight is 480.52 grams/ moles. Tucatinibis available as 50 mg and 150 mg oral film-coated tablets, containing the following inactive ingredients:Tablet core:Copovidone, crosvidone, sodium chloride, potassium chloride, sodium bicarbonate, colloidal silicon dioxide, magnesium stearate and microcrystalline cellulose. Coating:Yellow film coating:Polyvinyl alcohol, titanium dioxide, polyethylene glycol/Polyethylene glycol, talc and yellow iron oxide are not irradiated. Each tucatinib50mg tablet contains 10.10mg (0.25 8milliequivalents) potassium and 9.21mg (0.401milliequivalents) sodium. Each tucatinib150mg tablet contains 30.29mg (0.77 5milliequivalents) potassium and 27.64mg (1.202milliequivalents) sodium. There is a generic version of this drug in Bangladesh. The retail price of Everest Pharmaceuticals in Bangladesh is about 150mg30 tablets6000 yuan. The retail price of Ziska Pharmaceuticals in Bangladesh is around 4,500 yuan for 150 mg 30 tablets. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.